[1]
M. Olmedo-Muñoz and R. Recalde-Navarrete, “Cardiometabolic effect of sodium and glucosa cotransporter inhibitors type 2”, Salud, Ciencia y Tecnología, vol. 3, p. 563, Oct. 2023.